Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/006280 stock hub

KRX/006280 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/006280is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.6T

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/006280

In the news

Latest news · KRX/006280

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E41.5

P25 9.8P50 17.1P75 31.9

Trailing P/En/a

P25 12P50 23.1P75 39.5

ROE-2.1

P25 -17.1P50 0.7P75 8.5

ROIC2.8

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/006280 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

220

Groups with data

Currency

KRW

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	2,042
Enterprise value	KRW 2.7T
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7006280002
Last refreshed	2026-05-10
Market cap	KRW 1.6T
Price	KRW 138,100
Price currency	KRW
Rev Per Employee	975,161,162.49x
Sector	Healthcare
Sic	2836
Symbol	krx/006280
Website	https://www.gcbiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.3%
EV Earnings	-574.32x
EV/EBIT	24.44x
EV/EBITDA	13.59x
EV/FCF	99.05x
EV/Sales	1.35x
FCF yield	1.72%
Forward P/E	41.47x
P/B ratio	1.13x
P/S ratio	0.79x
PE Ratio10 Y	68.93x
PE Ratio5 Y	76.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.41%
EBITDA Margin	7.81%
FCF margin	1.36%
Gross margin	27.75%
Gross Profit	KRW 552.6B
Gross Profit Growth	15%
Gross Profit Growth Q	15.45%
Gross Profit Growth3 Y	-1.6%
Gross Profit Growth5 Y	4.69%
Net Income	KRW -4.7B
Net Income Growth Years	2%
Pretax Margin	-1.77%
Profit Margin	-0.23%
Profit Per Employee	KRW -2.3M
ROA	1.48
Roa5y	1.41
ROCE	3.71
ROE	-2.06
Roe5y	1.65
ROIC	2.84
Roic5y	2.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.86%
Cagr15y	1.11%
Cagr1y	16.74%
Cagr20y	6.23%
Cagr3y	4.06%
Cagr5y	-17.15%
Div CAGR10	1.84%
Div CAGR3	0%
Div CAGR5	-5.59%
EPS Growth Years	2
FCF Growth Q	-25.14%
FCF Growth3 Y	-23.76%
OCF Growth Q	18.37%
OCF Growth10 Y	8.2%
OCF Growth3 Y	-5.84%
OCF Growth5 Y	22.56%
Revenue Growth	18.54x
Revenue Growth Q	12.91x
Revenue Growth Quarters	6x
Revenue Growth Years	2x
Revenue Growth3 Y	5.18x
Revenue Growth5 Y	5.77x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.7
Assets	KRW 3T
Cash	KRW 50.8B
Current Assets	KRW 1.4T
Current Liabilities	KRW 1.1T
Debt	KRW 982.1B
Debt EBITDA	KRW 6.32
Debt Equity	KRW 0.7
Debt FCF	KRW 36.24
Equity	KRW 1.4T
Interest Coverage	1.35
Liabilities	KRW 1.6T
Long Term Assets	KRW 1.6T
Long Term Liabilities	KRW 431B
Net Cash	KRW -931.3B
Net Cash By Market Cap	KRW -59.09
Net Debt EBITDA	KRW 5.99
Net Debt Equity	KRW 0.67
Net Debt FCF	KRW 34.37
Tangible Book Value	KRW 974.4B
Tangible Book Value Per Share	KRW 85,375
WACC	6.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.2
Inventory Turnover	1.76
Net Working Capital	KRW 797.2B
Quick ratio	0.4
Working Capital	KRW 224.4B
Working Capital Turnover	KRW 6.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	KRW 1,500
Dividend Years	1
Dividend Yield	1.09%
Ex Div Date	2026-03-30
Last Dividend	KRW 1,500
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-8.25%
1Y total return	16.72%
200-day SMA	144,700
3Y total return	12.69%
50-day SMA	146,382
50-day SMA vs 200-day SMA	50over200
5Y total return	-60.97%
All Time High	654,761.9
All Time High Change	-78.91%
All Time High Date	1995-01-04
All Time Low	4,857.1
All Time Low Change	2,743.24%
All Time Low Date	2003-03-17
ATR	4,558.1
Beta	0.75
Beta1y	0.72
Beta2y	0.64
Ch YTD	-13.14
High	149,600
High52	183,800
High52 Date	2026-02-12
High52ch	-24.86%
Low	137,300
Low52	117,100
Low52 Date	2025-05-12
Low52ch	17.93%
Ma50ch	-5.66%
Price vs 200-day SMA	-4.56%
RSI	41.21
RSI Monthly	48.58
RSI Weekly	42.84
Sharpe ratio	0.47x
Sortino ratio	0.84
Total Return	1.09%
Tr YTD	-12.27
Tr15y	17.98%
Tr1m	-0.22%
Tr1w	0.44%
Tr3m	-15.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 67.8B
Operating Income Growth	111.6
Operating Income Growth3 Y	-5.64
Operating Income Growth5 Y	6.2
Operating margin	3.41

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,452,063%
Net Borrowing	130,275,384,960
Shares Insiders	0.94%
Shares Institutions	14.4%
Shares Out	11,413,127
Shares Qo Q	-0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 27.1B
Average Volume	39,620.7x
Bv Per Share	106,673.4
CAPEX	KRW -72.4B
Ch10y	-15.79
Ch15y	1.05
Ch1m	-0.22
Ch1w	0.44
Ch1y	15.57
Ch20y	166.6
Ch3m	-15.95
Ch3y	9.26
Ch5y	-62.98
Ch6m	7.56
Change	1.1%
Change From Open	-4.96
Close	136,600
Days Gap	6.37
Depreciation Amortization	87,655,000,000
Dollar Volume	13,436,163,300
Earnings Date	2026-05-15
EBIT	KRW 67.8B
EBITDA	KRW 155.5B
EPS	KRW -410
F Score	5
FCF	KRW 27.1B
FCF EV Yield	1.01x
FCF Per Share	KRW 2,375
Financing CF	111,580,177,850
Fiscal Year End	December
Founded	1,967
Goodwill	118,069,000,000
Income Tax	KRW -5.6B
Investing CF	-186,790,057,520
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Last Split Date	2013-06-07
Last Split Type	Forward
Ma150	147,280
Ma150ch	-6.23%
Ma20	142,440
Ma20ch	-3.05%
Net CF	26,808,880,740
Next Earnings Date	2026-05-15
Open	145,300
P FCF Ratio	58.16
P OCF Ratio	15.85
Payment Date	2026-04-21
Position In Range	6.5
Ppne	960,460,729,420
Price Date	2026-05-08
Price EBITDA	KRW 10.14
Ptbv Ratio	1.62
Relative Volume	2.46x
Revenue	1,991,279,093,810x
Tax By Revenue	-0.28x
Tr20y	235.08%
Tr6m	8.63%
Volume	97,293
Z Score	1.8

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/006280 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$1500 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-5.6%

0 consecutive years of growth

Total shareholder yield

+1.1%

Next ex-dividend date: 2026-03-30

Performance

KRX/006280 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/006280?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.4%

Share of float held by funds and institutions

Insider ownership

+0.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

KRX/006280 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.2

Neutral momentum band

Price vs 200-day MA

-4.6%

50/200-day relationship not available

Beta (5Y)

0.75

Less volatile than the market

Sharpe ratio

0.47

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/006280

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/006280 stock rating?

krx/006280 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/006280 analysis?

The full report lives at /stocks/krx/006280/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/006280?

The latest report frames krx/006280 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/006280 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.